... 70 million doses each month of the two approved shots — AstraZeneca, made by the Serum Institute of India, and another by Bharat Biotech.
News
- As cases grow, India's vaccination campaign falters
- Unsure vaccine waiver will help, some leaders urge exports
Meanwhile, Germany, a research powerhouse with strong biotech and pharmaceutical sectors, spoke out against waiving the protections — and also ...
- Initial public offerings scheduled to debut next week
Proposed Nasdaq symbol TALS. Business: Phase 3 biotech developing allongeneic cell therapies for organ transplant recipients. Waterdrop - Beijing, ...
- Calithera: Q1 Earnings Snapshot
SOUTH SAN FRANCISCO, Calif. (AP) _ Calithera Biosciences Inc. (CALA) on Thursday reported a loss of $20.4 million in its first quarter.
- Enanta Pharmaceuticals: Fiscal Q2 Earnings Snapshot
The average estimate of five analysts surveyed by Zacks Investment Research was for a loss of 94 cents per share. The biotechnology company posted ...